Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids

A Putative Microcin Amplifies Shiga Toxin 2a Production of Escherichia coli O157:H7

(2019) Hillary M. Mosso et al.   JOURNAL OF BACTERIOLOGY

The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ

(2018) Susanne Bury et al.   Frontiers in Microbiology

Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features

(2018) Niv Zmora et al.   CELL

Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Escherichia coli

(2017) Sayali S. Karve et al.   PLoS One

Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application

(2016) Bingming Ou et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Microcins mediate competition among Enterobacteriaceae in the inflamed gut

(2016) Martina Sassone-Corsi et al.   NATURE

Metagenomic Sequencing with Strain-Level Resolution Implicates Uropathogenic E. coli in Necrotizing Enterocolitis and Mortality in Preterm Infants

(2016) Doyle V. Ward et al.   Cell Reports

The interplay ofEscherichia coliO157:H7 and commensalE. coli: the importance of strain-level identification

(2016) Hillary M. Figler et al.   Expert Review of Gastroenterology & Hepatology

Coculture of Escherichia coli O157:H7 with a Nonpathogenic E. coli Strain Increases Toxin Production and Virulence in a Germfree Mouse Model

(2015) Kakolie Goswami et al.   INFECTION AND IMMUNITY

Escherichia coli EDL933 Requires Gluconeogenic Nutrients To Successfully Colonize the Intestines of Streptomycin-Treated Mice Precolonized with E. coli Nissle 1917

(2015) Silvia A. C. Schinner et al.   INFECTION AND IMMUNITY

Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli

(2015) Mashkoor Mohsin et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Complete genome sequence of the Gram-negative probiotic Escherichia coli strain Nissle 1917

(2014) Marten Reister et al.   JOURNAL OF BIOTECHNOLOGY

An Escherichia coli Nissle 1917 Missense Mutant Colonizes the Streptomycin-Treated Mouse Intestine Better than the Wild Type but Is Not a Better Probiotic

(2013) Jimmy Adediran et al.   INFECTION AND IMMUNITY

TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signaling in HT-29/B6 cells

(2013) N A Hering et al.   Mucosal Immunology

Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine

(2013) Rosalie Maltby et al.   PLoS One

Probiotics: Properties, Examples, and Specific Applications

(2013) J. Behnsen et al.   Cold Spring Harbor Perspectives in Medicine

Risk Factors for the Hemolytic Uremic Syndrome in Children Infected With Escherichia coli O157:H7: A Multivariable Analysis

(2012) C. S. Wong et al.   CLINICAL INFECTIOUS DISEASES

Mouse Models ofEscherichia coliO157:H7 Infection and Shiga Toxin Injection

(2011) Krystle L. Mohawk et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Generating human intestinal tissue from pluripotent stem cells in vitro

(2011) Kyle W McCracken et al.   Nature Protocols

Different Classes of Antibiotics Differentially Influence Shiga Toxin Production

(2010) C. M. McGannon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host

(2010) K. Gronbach et al.   INFECTION AND IMMUNITY

A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972

(2010) Rebecca Munk Vejborg et al.   MOLECULAR GENETICS AND GENOMICS

Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation

(2010) Viktoria Hancock et al.   MOLECULAR GENETICS AND GENOMICS

Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro

(2010) Jason R. Spence et al.   NATURE

Precolonized Human Commensal Escherichia coli Strains Serve as a Barrier to E. coli O157:H7 Growth in the Streptomycin-Treated Mouse Intestine

(2009) M. P. Leatham et al.   INFECTION AND IMMUNITY

Microcins and urovirulence in Escherichia coli

(2009) María F. Azpiroz et al.   MICROBIAL PATHOGENESIS

Probiotic Escherichia coli Nissle 1917 Versus Placebo for Treating Diarrhea of Greater Than 4 Days Duration in Infants and Toddlers

(2009) Jobst Henker et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL